Xuewu Liang

7PUBLICATIONS
5CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesProteins and peptidesBiomolecular modelling and designMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 17, 2025
Discovery of Novel RNA Demethylase FTO Inhibitors Featuring an Acylhydrazone Scaffold with Potent Antileukemia Activity.

Xuewu Liang, Yue Huang, Hairu Ren

|Aug 23, 2024
Discovery of Novel 2-Aminopyridine-Based and 2-Aminopyrimidine-Based Derivatives as Potent CDK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors and Hematological Malignancies.

Abdusaid Saidahmatov, Jianan Li, Shihao Xu

|Jul 22, 2024
Discovery of Novel Pyrimidine-Based Derivatives as Nav1.2 Inhibitors with Efficacy in Mouse Models of Epilepsy.

Guoxue He, Yueming Zheng, Shunzhen Chang

|Feb 13, 2024
Development of Potent MALT1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidin-7(6H)-one" Scaffold for the Treatment of B Cell Lymphoma.

Xuewu Liang, Haolan Yu, Renwen Liang

|Nov 20, 2023
The new direction of drug development: Degradation of undruggable targets through targeting chimera technology.

Xuewu Liang, Hairu Ren, Fengyang Han

|Sep 02, 2022
Discovery of Novel Imidazo[4,5-c]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Intestinal Homeostasis.

Xuewu Liang, Yongle Xie, Xuyi Liu

Pageof 2

Frequent Collaborators

7 joint publications

Hong Liu

1 joint publications

Yu Zhou

1 joint publications

Fengyang Han

1 joint publications

Zhaobing Gao